Accordingly, we can infer that hsa-miR-24 and p53 signaling pathway should provide an important contribution to understand the mechanisms of radiosensitivity in human NPC and that it may represent a potential therapeutic target. The gene discussed is TP53; the disease is nasopharyngeal carcinoma.